US 7662815
Diaryl ether β2 adrenergic receptor agonists
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7662815 (Diaryl ether β2 adrenergic receptor agonists) held by Theravance, Inc. expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P15/06, A61P25/00